Search Results 251-260 of 15984 for melatonin receptor agonists

  1. Hormone Therapy For Breast Cancer Clinical Trials - Mayo Clinic Research

    This phase I trial studies the side effects and the best dose of Z-endoxifen hydrochloride in treating patients with estrogen receptor-positive (ER+) breast ...

  2. A Study to Determine the Effectiveness and Safety of Luspatercept in Patients with Myelodysplastic/ Myeloproliferative Neoplasms with Ring Sideroblasts and Thrombocytosis - Mayo Clinic

    ... agonists for prostate cancer, and treatment with bisphosphonates and receptor activator of nuclear factor kappa-B ligand (RANKL) inhibitors) for their cancer.

  3. Focus Areas - Department of Molecular Pharmacology and Experimental Therapeutics Research - Mayo Clinic Research

    Cell signaling in G protein-coupled and tyrosine kinase receptor systems ... Receptor Biology: Steven M. Sine; Stem Cell and Regenerative Metabolism ...

  4. Health Topics - Mayo Clinic News Network

    Melatonin use in children: Is a sleep aid supplement safe? ... Mayo Clinic Minute: Can aspirin make your breathing worse? Deb Balzer. March 26, 2024.

  5. Sleep Medicine Fellowship (Minnesota) - Department and Faculty

    Department and faculty information for the Sleep Medicine Fellowship at Mayo Clinic School of Graduate Medical Education in Rochester, Minnesota.

  6. Digestive Diseases News - Medical Professionals - Mayo Clinic

    Management of obesity within hepatology clinics. Researchers discuss the role of dietary supplements, glucagon-like peptide 1 receptor agonists, sodium-glucose ...

  7. Brain Tumor Clinical Trials - Mayo Clinic Research

    Memantine hydrochloride may enhance cognitive function by binding to and inhibiting channels of receptors located in the central nervous system. Radiation ...

  8. Pulmonary Medicine Clinical Trials - Medical Professionals

    The purpose of this study is to establish the effectiveness of a combination of an inhaled corticosteroid and a beta agonist compared to placebo for the ...

  9. Comparing Retreatment of 177Lu-DOTATATE PRRT Versus Everolimus in Patients With Metastatic Unresectable Midgut Neuroendocrine Tumors, NET RETREAT Trial - Mayo Clinic

    The purpose of this study is tol compare the effect of retreatment with 177Lu-DOTATATE peptide receptor radionuclide therapy (PRRT) to the usual approach of ...

  10. Lung Tumors Clinical Trials - Mayo Clinic Research

    ... receptor positive bronchial neuroendocrine tumors that have spread to other places in the body (advanced). Radioactive drugs, such as lutetium Lu 177 ...